The role of Acticoat™ with nanocrystalline silver in the management of burns

被引:250
作者
Dunn, K [1 ]
Edwards-Jones, V
机构
[1] Wythenshawe Hosp, Burns Unit, Manchester M23 9LT, Lancs, England
[2] Manchester Metropolitan Univ, Dept Microbiol, Manchester M15 6BH, Lancs, England
关键词
D O I
10.1016/S0305-4179(04)90000-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Silver is an effective antimicrobial agent, but older silver-containing formulations are rapidly inactivated by the wound environment, requiring frequent replenishment. These older formulations may also be pro-inflammatory and may delay healing. Acticoat(TM) (Smith & Nephew Hull, UK) is a relatively new form of silver antimicrobial barrier dressing which helps avoid the problems of earlier agents. It has rapid and sustained bactericidal activity, and because of this may reduce inflammation and promote healing, Despite extensive testing and clinical experience, no evidence has emerged of resistance or cytotoxicity to nanocrystalline silver. This article collects together a number of presentations that were given at the 2003 European Burns Association Meeting on the use of Acticoa(TM) in the management of burns. (C) 2004 Published by Elsevier B.V All rights reserved.
引用
收藏
页码:S1 / S9
页数:9
相关论文
共 37 条
[11]  
Grier N, 1983, DISINFECTION STERILI
[12]  
Gupta A, 1998, APPL ENVIRON MICROB, V64, P5042
[13]   INHIBITORY AND CIDAL ANTIMICROBIAL ACTIONS OF ELECTRICALLY GENERATED SILVER IONS [J].
HALL, RE ;
BENDER, G ;
MARQUIS, RE .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1987, 45 (09) :779-784
[14]   CYSTEINE PROTECTS NA,K-ATPASE AND ISOLATED HUMAN-LYMPHOCYTES FROM SILVER TOXICITY [J].
HUSSAIN, S ;
ANNER, RM ;
ANNER, BM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (03) :1444-1449
[15]  
Klein D G, 1995, Crit Care Nurs Clin North Am, V7, P627
[16]  
KUROYANAGI Y, 1991, Journal of Burn Care and Rehabilitation, V12, P106, DOI 10.1097/00004630-199103000-00004
[17]   Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins [J].
Li, XZ ;
Nikaido, H ;
Williams, KE .
JOURNAL OF BACTERIOLOGY, 1997, 179 (19) :6127-6132
[18]   ASSESSMENT OF SILVER-COATED URINARY CATHETER TOXICITY BY CELL-CULTURE [J].
LIEDBERG, H ;
LUNDEBERG, T .
UROLOGICAL RESEARCH, 1989, 17 (06) :359-360
[19]   COMPARISON OF THE INVITRO ACTIVITIES OF THE TOPICAL ANTIMICROBIALS AZELAIC ACID, NITROFURAZONE, SILVER SULFADIAZINE AND MUPIROCIN AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
MAPLE, PAC ;
HAMILTONMILLER, JMT ;
BRUMFITT, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (06) :661-668
[20]   INVITRO TOXICITY OF TOPICAL ANTIMICROBIAL AGENTS TO HUMAN-FIBROBLASTS [J].
MCCAULEY, RL ;
LINARES, HA ;
PELLIGRINI, V ;
HERNDON, DN ;
ROBSON, MC ;
HEGGERS, JP .
JOURNAL OF SURGICAL RESEARCH, 1989, 46 (03) :267-274